Lei Wang

Lei Wang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
XLXiaoming Liu
Xiaoming Liu
XZXuejiao Zeng
Xuejiao Zeng
JMJinli Mahe
Jinli Mahe
KGKai Guo
Kai Guo
PHPanpan He
Panpan He
LJLipeng Jing
Lipeng Jing
Dyslipidemia, a condition implying high cardiovascular risks, has been widely studied on its potential nutrition interventions, including functional foods. This study aims to examine the effect of nattokinase monascus supplements (NMSs) on cardiovascular biomarkers and carotid intima-media thickness (CIMT) in patients with dyslipidemia. A total of 113 eligible subjects were randomly assigned to receive either NMSs or a placebo (55 and 58, respectively). After a 120-day intervention, there were significant mean absolute changes in total cholesterol (TC), low-density cholesterol (LDL-C), non-high-density cholesterol (non-HDL-C), and low-density cholesterol to high-density cholesterol ratio (LDL-C to HDL-C ratio), with values of −0.52 (95% CI: −0.51 to −0.54) mmol/L, −0.43 (95% CI: −0.45 to −0.41) mmol/L, −0.52 (95% CI: −0.52 to −0.52) mmol/L, and −0.29 (95% CI: −0.30 to −0.28) mmol/L, respectively, between the two groups. However, no significant differences were found in triglycerides (TGs), high-density cholesterol (HDL-C), and CIMT. Furthermore, the results for lipids and CIMT remained essentially unchanged after adjusting for various confounding factors using the analysis of covariance model. There were no significant differences in coagulation, liver function, renal function, or other indicators. No intervention-related adverse events, such as mouth ulcers, drooling, and stomach pain, were reported. The study results demonstrate that NMSs can ameliorate lipid levels (TC, LDL-C, non-HDL-C, and the LDL-C to HDL-C ratio) without the occurrence of adverse events. However, it did not significantly affect serum TG, HDL-C, and CIMT.

13 September 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KGKai Guo
Kai Guo
XZXuejiao Zeng
Xuejiao Zeng
XLXiaoming Liu
Xiaoming Liu
PHPanpan He
Panpan He
ZZZhiwei Zhang
Zhiwei Zhang
LJLipeng Jing
Lipeng Jing
Healthy lifestyle reduces the risk of inflammation-related diseases. This study assessed how lifestyle changes affect inflammatory cytokines over 2 months. Involving 179 apparently healthy participants recruited from community, collecting data on lifestyles (smoking, alcohol, BMI, daily activity, sleep, diet) and measured inflammatory cytokines (TNF-α, IL-1β, IL-17A, CRP, IL-8, IL-18, IFN-γ) plus pepsinogens (PG I, PG II) at the baseline and 2-month follow-up. The combined adverse lifestyle score is the sum of scores across six lifestyles, with higher scores indicating more adverse lifestyle factors. Use multiple linear regression and mixed linear models to analyze the relationship between the changes in lifestyle and inflammatory cytokines (follow-up values minus baseline values). For every 1-point increase in combined adverse lifestyle score, IL-17A increased by 0.98 (95% CI 0.23, 1.73) pg/mL, IFN-γ increased by 1.79 (95% CI 0.39, 3.18) pg/mL. Decreased changes in daily activity were associated with higher IL-17A (β = 1.83, 95% CI 0.53, 3.13) and IFN-γ (β = 2.59, 95% CI 0.9, 4.98). Excluding daily activity, changes in combined adverse lifestyle scores were not associated with changes in inflammatory cytokines. Lifestyle improvements at 2-month intervals may reduce TNF-α, IL-17A and IFN-γ, with daily activity making the greatest contribution.

17 March 2026 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Open access
PDF file
JZJiali Zhang
Jiali Zhang
LFLiming Fan
Liming Fan
ZZZhen-chang Zhang
Zhen-chang Zhang
LWLei Wang
Lei Wang
The bidirectional communication between the gut microbiota and the central nervous system (CNS), known as the gut–brain axis, has become a key focus in neuroscience research. Short-chain fatty acids (SCFAs)—major metabolites produced by gut microbes through the fermentation of dietary fiber—can cross the blood–brain barrier (BBB) and directly modulate microglial function, thereby influencing neuroinflammatory processes. This review systematically examines the mechanisms by which SCFAs (primarily acetate, propionate and butyrate) regulate microglial activation states, cytokine secretion, phagocytic capacity, and metabolic phenotypes in the context of neurological and psychiatric disorders, including Alzheimer’s disease, Parkinson’s disease, stroke and depression. Current evidence suggests that SCFAs generally suppress excessive microglial activation and mitigate neuroinflammation, although their effects are context dependent and mediated through multiple pathways, such as histone deacetylase (HDAC) inhibition and G-protein-coupled receptor signaling. Overall, this review provides a theoretical foundation and new insights into targeting gut microbiota and their metabolites for the treatment of neuroinflammation-related disorders.